Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.
Pagnoux
C
C
Lutz-Zarrouk
V
V
Michel
M
M
Schaeffer
A
A
Godeau
B
B
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019934:International Normalized Ratio; D020767:Intracranial Thrombosis / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D013792:Thalidomide; D014859:Warfarin